Specifications
Species Reactivity
Rat; Human
Immunogen
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human EXOSC3 aa 1-100 (N terminal). The exact sequence is proprietary.Database link: Q9NQT5
Applications
Application Notes
WB: 1/10000 - 1/50000; IHC-P: 1/50; Flow Cyt: 1/100; IP: 1/50 - 1/70; ICC/IF: 1/100;
Target
Alternative Names
EXOSC3; exosome component 3; exosome complex component RRP40; CGI 102; CGI 102 protein; exosome component Rrp40; hRrp 40; hRrp40p; p10; RRP40; Rrp40p; exosome complex exonuclease RRP40; ribosomal RNA-processing protein 40; CGI-102; hRrp-40; bA3J10.7; MGC7
Product Background
Antigen Description
EXOSC3 is a component of the exosome 3->5 exoribonuclease complex, a complex that degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3 untranslated regions. It is required for the 3processing of the 7S pre-RNA to the mature 5.8S rRNA. Has a 3-5 exonuclease activity. [Swiss-Prot]
Pathway
Activation of Genes by ATF4, organism-specific biosystem; Deadenylation-dependent mRNA decay, organism-specific biosystem; Destabilization of mRNA by Butyrate Response Factor 1 (BRF1), organism-specific biosystem; Destabilization of mRNA by KSRP, organism-specific biosystem; Destabilization of mRNA by Tristetraprolin (TTP), organism-specific biosystem; Diabetes pathways, organism-specific biosystem; Disease, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-7943 in a publication?
Let us know and earn a reward for your research.